John M. Herndon

7.1k total citations · 2 hit papers
44 papers, 4.2k citations indexed

About

John M. Herndon is a scholar working on Immunology, Molecular Biology and Ophthalmology. According to data from OpenAlex, John M. Herndon has authored 44 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 13 papers in Molecular Biology and 9 papers in Ophthalmology. Recurrent topics in John M. Herndon's work include Immunotherapy and Immune Responses (15 papers), Immune Cell Function and Interaction (10 papers) and Phagocytosis and Immune Regulation (8 papers). John M. Herndon is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), Immune Cell Function and Interaction (10 papers) and Phagocytosis and Immune Regulation (8 papers). John M. Herndon collaborates with scholars based in United States, Switzerland and France. John M. Herndon's co-authors include Thomas A. Ferguson, Thomas S. Griffith, Douglas R. Green, Thomas A. Ferguson, David G. DeNardo, Brett L. Knolhoff, William G. Hawkins, Yu Zhu, Hirotaka Kazama and George Hoppe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

John M. Herndon

44 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy

2016 754 citations Brett L. Knolhoff, Yu Zhu et al. profile →
Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression

2017 585 citations Yu Zhu, John M. Herndon et al. Immunity profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John M. Herndon United States	26	2.6k	1.5k	1.2k	374	353	44	4.2k
Hélène Merle‐Béral France	37	1.7k 0.6×	874 0.6×	1.1k 0.9×	183 0.5×	125 0.4×	157	4.3k
Silvia Montaner United States	31	631 0.2×	1.6k 1.0×	1.9k 1.5×	395 1.1×	956 2.7×	60	4.2k
M. Asif Amin United States	32	1.0k 0.4×	707 0.5×	1.2k 1.0×	117 0.3×	362 1.0×	61	2.8k
Jeffrey Eastham‐Anderson United States	26	2.2k 0.8×	1.0k 0.7×	1.5k 1.2×	76 0.2×	236 0.7×	35	4.2k
Ruggero Pardi Italy	39	1.9k 0.7×	621 0.4×	1.7k 1.4×	26 0.1×	551 1.6×	96	4.7k
Akrit Sodhi United States	33	532 0.2×	1.4k 0.9×	1.7k 1.4×	1.2k 3.1×	740 2.1×	64	4.3k
Kishore K. Wary United States	31	718 0.3×	547 0.4×	2.8k 2.3×	96 0.3×	842 2.4×	66	4.9k
Masamichi Goto Japan	35	626 0.2×	1.2k 0.8×	1.6k 1.3×	32 0.1×	322 0.9×	114	3.5k
Mogens Holst Nissen Denmark	32	1.2k 0.4×	331 0.2×	894 0.7×	621 1.7×	57 0.2×	103	2.5k
Daniela Coltrini Italy	28	681 0.3×	270 0.2×	1.3k 1.1×	94 0.3×	290 0.8×	52	2.2k

Countries citing papers authored by John M. Herndon

Since Specialization

Citations

This map shows the geographic impact of John M. Herndon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Herndon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Herndon more than expected).

Fields of papers citing papers by John M. Herndon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Herndon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Herndon. The network helps show where John M. Herndon may publish in the future.

Co-authorship network of co-authors of John M. Herndon

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Herndon. A scholar is included among the top collaborators of John M. Herndon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Herndon. John M. Herndon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Storrs, Erik, Daniel Cui Zhou, Michael C. Wendl, et al.. (2022). Pollock: fishing for cell states. Bioinformatics Advances. 2(1). vbac028–vbac028. 2 indexed citations

Lander, Varintra E., Jad I. Belle, Natalie L. Kingston, et al.. (2022). Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint Blockade. Cancer Discovery. 12(12). 2774–2799. 66 indexed citations

Grierson, Patrick, Iftikhar Ali Khawar, Daoxiang Zhang, et al.. (2021). The MK2/Hsp27 axis is a major survival mechanism for pancreatic ductal adenocarcinoma under genotoxic stress.. PubMed. 13(622). eabb5445–eabb5445. 13 indexed citations

Li, Qiong, Yali Chen, Daoxiang Zhang, et al.. (2019). IRAK4 mediates colitis-induced tumorigenesis and chemoresistance in colorectal cancer. JCI Insight. 4(19). 31 indexed citations

Panni, Roheena Z., John M. Herndon, Brett L. Knolhoff, et al.. (2018). CD11b hyperactivation improves response to immunotherapy in pancreatic cancer. HPB. 20. S536–S537. 1 indexed citations

Zhu, Yu, John M. Herndon, Dorothy K. Sojka, et al.. (2017). Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression. Immunity. 47(2). 323–338.e6. 585 indexed citations breakdown →

Tiriveedhi, Venkataswarup, John M. Herndon, Lijin Li, et al.. (2014). Safety and Preliminary Evidence of Biologic Efficacy of a Mammaglobin-A DNA Vaccine in Patients with Stable Metastatic Breast Cancer. Clinical Cancer Research. 20(23). 5964–5975. 75 indexed citations

Li, Lijin, Sojung Kim, John M. Herndon, et al.. (2012). Cross-dressed CD8α ⁺ /CD103 ⁺ dendritic cells prime CD8 ⁺ T cells following vaccination. Proceedings of the National Academy of Sciences. 109(31). 12716–12721. 63 indexed citations

Griffith, Thomas S., Hirotaka Kazama, Rebecca L. VanOosten, et al.. (2007). Apoptotic Cells Induce Tolerance by Generating Helpless CD8+ T Cells That Produce TRAIL. The Journal of Immunology. 178(5). 2679–2687. 70 indexed citations

10.

Unsinger, Jacqueline, John M. Herndon, Christopher G. Davis, et al.. (2006). The Role of TCR Engagement and Activation-Induced Cell Death in Sepsis-Induced T Cell Apoptosis. The Journal of Immunology. 177(11). 7968–7973. 36 indexed citations

11.

Herndon, John M., Patrick M. Stuart, & Thomas A. Ferguson. (2005). Peripheral Deletion of Antigen-Specific T Cells Leads to Long-Term Tolerance Mediated by CD8+ Cytotoxic Cells. The Journal of Immunology. 174(7). 4098–4104. 32 indexed citations

12.

Luker, Gary D., et al.. (2004). Termination of Antigen-Specific Immunity by CD95 Ligand (Fas Ligand) and IL-10. The Journal of Immunology. 173(3). 1519–1525. 18 indexed citations

13.

Ferguson, Thomas A., Patrick M. Stuart, John M. Herndon, & Thomas S. Griffith. (2003). Apoptosis, tolerance, and regulatory T cells – old wine, new wineskins. Immunological Reviews. 193(1). 111–123. 48 indexed citations

14.

Lee, Hae‐Ock, et al.. (2002). TRAIL: A Mechanism of Tumor Surveillance in an Immune Privileged Site. The Journal of Immunology. 169(9). 4739–4744. 85 indexed citations

15.

Ferguson, Thomas A., et al.. (2002). Uptake of Apoptotic Antigen-Coupled Cells by Lymphoid Dendritic Cells and Cross-Priming of CD8+ T Cells Produce Active Immune Unresponsiveness. The Journal of Immunology. 168(11). 5589–5595. 163 indexed citations

16.

Elzey, Bennett D., et al.. (2001). Regulation of Fas Ligand-Induced Apoptosis by TNF. The Journal of Immunology. 167(6). 3049–3056. 60 indexed citations

17.

Gao, Yakun, John M. Herndon, Hui Zhang, Thomas S. Griffith, & Thomas A. Ferguson. (1998). Antiinflammatory Effects of CD95 Ligand (FasL)-induced Apoptosis. The Journal of Experimental Medicine. 188(5). 887–896. 193 indexed citations

18.

Ferguson, Thomas A., et al.. (1997). Apoptotic cell death and il-10 production in the eye are essential for the induction of immune deviation. Investigative Ophthalmology & Visual Science. 38(4). 2 indexed citations

19.

Griffith, Thomas S., Xinhong Yu, John M. Herndon, Douglas R. Green, & Thomas A. Ferguson. (1996). CD95-Induced Apoptosis of Lymphocytes in an Immune Privileged Site Induces Immunological Tolerance. Immunity. 5(1). 7–16. 329 indexed citations

20.

Bonilla‐Félix, Melvin, L. Lee Hamm, John M. Herndon, & V. Matti Vehaskari. (1992). Response of cortical collecting ducts from remnant kidneys to arginine vasopressin. Kidney International. 41(5). 1150–1154. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact